Status:
COMPLETED
Treatment of Primary Type I Pterygia With Argon Laser
Lead Sponsor:
Instituto de Oftalmología Fundación Conde de Valenciana
Conditions:
Pterygium
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Introduction: Pterygium is a wing shape degenerative and hyperplastic growth of the bulbar conjunctiva extending onto the cornea, most commonly on the nasal side. Management of pterygium can be medica...
Detailed Description
Pterygium is a wing shape degenerative and hyperplastic growth of the bulbar conjunctiva extending onto the cornea, most commonly on the nasal side. Management of pterygium can be medical, surgical or...
Eligibility Criteria
Inclusion
- Patients who had had symmetric type I pterygia in both eyes
- Assessments for the 6 month follow-up period after argon laser treatment
Exclusion
- Patients with diabetes Mellitus, collagenopathies, previous ocular surgeries, and pregnant patients
Key Trial Info
Start Date :
March 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT03485001
Start Date
March 1 2014
End Date
October 1 2016
Last Update
April 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Oftalmología
Mexico City, Mexico, 06800